Asst. Prof. MD.

Görkem Türkkan

Radiation Oncology

Interests

  • Central nervous system tumors, prostate cancer, bladder cancer
  • Lung cancer, gastrointestinal cancers, skin cancer
  • Breast cancer, head and neck cancers, gynecological tumors
  • Stereotactic radiotherapy, intensity weighted radiotherapy (IMRT)
  • Palliative radiotherapy

4
h-index
Education:
  • Zonguldak Science High School, 2003
  • Gulhane Military Medical Academy Faculty Of Medicine, 2003-2008
  • Zonguldak Karaelmas University (Bülent Ecevit University) Faculty Of Medicine, 2009
  • Trakya University Faculty Of Medicine, Department Of Radiation Oncology, 2012-2016

Experience:
  • Liv Hospital Ulus, Department Of Radiation Oncology (2021-)
  • Thoracic radiotherapy, stereotactic radiotherapy-associated pulmonary toxicity, proton therapy, Maastricht University Medical Centre, Department of radiation oncology-MAASTRO Clinic, the Netherlands, Clinical Researcher (March-June 2020)
  • Muğla Sitki Koçman University Faculty Of Medicine, Department Of Radiation Oncology, Doctor Faculty Member, Head Of Department (2019-2021)
  • Ministry Of Health Manisa City Hospital, Department Of Radiation Oncology, Specialist Doctor (2019)
  • Ministry Of Health Edirne Sultan 1.Murat State Hospital, Department Of Radiation Oncology, Specialist Doctor (2017-2019)
  • Trakya University Faculty Of Medicine, Department Of Radiation Oncology, Research Assistant Doctor (2012-2016)
Publications: 17
  • Turkkan G, Alkan A, Akarken I, Tanrıverdi Ö, Şahin H. active surveillance perspectives of radiation oncologists, medical oncologists and urologists in the treatment of prostate cancer. Türk J Oncol 2021; 36 (1):546-55.
  • Turkkan G, Willems Y, Hendriks LH, Mostard R, Conemans L, Gietema HA, Mitea C, Peeters s, De Ruysscher D. idiopathic pulmonary fibrosis: current knowledge, Future Perspectives and importance in Radiation Oncology. Radyother Forearm. 2020 November 24: S0167-8140 (20)31190-7.
  • Turkkan G., Ed. What we should not forget in brachytherapy: the inverse square law. Türk J Oncol 2020; 1 (3).
  • TÜRKKAN G, Alkan A, stakeholder S, Tanrıverdi Ö, Karakaş Y, Karadurmuş N, calm a, clean S, Harpaci E, Akın M, Violet S, sen CA, In Peace i. demographic and clinical characteristics of marginal zone lymphomas: a retrospective study of the Turkish Oncology Group (TOG). Indian J Hematol Blood Transfusion. 2020 October; 36 (4): 640-645.
  • Alkan A, Belt, steel SY, uyan S, Iron Pektash S, Oral Tapan Ö, Gokdogan O, Turkkan G, Young S, Tanrıverdi Ö. Treatment of glottic squamous cell carcinoma with cutaneous metastases. Ozal Medical Center Journal Of Medicine Practice. 2020 February 6: 1078155219900782.
  • TÜRKKAN G, doğan C, Tek B. Bicalutamide-related hallucinations in a patient with metastatic prostate cancer: a case report. Ozal Medical Center Journal Of Medicine Practice. 2020;26(4):1029-1031.
  • TÜRKKAN G, Çaloğlu M, ÇALOĞLU VY, Karasalihoğlu AR, doğan M, Uzal C. evaluation of swallowing function with clinical and dosimetric parameters in head and neck cancer patients receiving radio(chemo)therapy. Integer. J. Radiat. ARS., October 2019; 17(4): 625-632.
  • Alkan A, TÜRKKAN G, Tanrıverdi d. Vitamin D deficiency in oncology practice-more ways to pass. Support Cancer Care. 2019;27(12):4385.
  • Alkan A, TÜRKKAN G, Tanrıverdi d. Folic acid: a new weapon for mucositis? Clin Genitourin Cancer. 2019; 17 (5):e885.
  • Delen E, Akıncı AT, TÜRKKAN G, Yalta TD, Şimşek O. Hemangiopericitoma at the craniovertebral Junction: a case report. EJMO 2019; 3 (1):73-75.
  • Turkkan G, Agdogan O, Saynak M, Uygun AC, Ustun F. Recurrent Merkel cell carcinoma of the Gluteal region: a case report. There's The Dermatol. 2019; 32 (1):e12749.
  • Saynak M, Nurlu D, Chukurcayir F, Turkkan G, Uzunoglu S. treatment of systemic consolidation after chemotherapy in the treatment of rectal cancer. Biomed J Science And Technology Res 3 (5) - 2018.
  • Turkkan G, Caloglu M, Master U, Caloglu VY, respect HM, Uzal C. recurrent intracranial Meningeal Hemangiopericitoma with isolated bone metastasis: case report and literature review. Türk J Oncol 2017; 32 (1):25-30.
  • Tastekin E, Caloglu VY, Durankus NK, Sut N, Turkkan G, Can N, Puyan FO, Caloglu M. Survival expression in oropharyngeal carcinomas, HPV positivity and its association with microvessel density and survival time. Arch Med Sci. 2017 October; 13 (6): 1467-1473.
  • Koçak Z, TÜRKKAN G, ÇALOĞLU VY, Saynak M. Combination of Belt and radio therapy. Turkey Clinics J Radiat Oncol-Special Issues 2015; 1 (3):74-9.
  • Caloglu VY, Caloglu M, Yalta TD, Aktoz T, Nurlu D, Durankus NK, Arda E, Turkkan G, Pearl O. acute renal toxicity due to radiation: protective effect of L-carnitine against amifostine. Integer. J. Radiat. ARS., October 2015; 13(4): 317-324.
  • Akdere H, CALOGLU VY, Tastekin E, Caloglu M, Turkkan G, Merichliler M, Mehmet Burgazli K. acute histopathological responses of testicular tissues after different fractional abdominal irradiation in rats. Postgraduate Medical. 2015 January; 127 (1):73-7.
  • TROD (Turkish Society of radio oncology)
  • ESTRO (European Society for Radiation Oncology)
Selected Verbal Statement 3.lük Award:
Alkan A, Turkkan G, Tanrıverdi Ö, Nazlı O. Effect Of Proton Pump Inhibitor Use On Response In Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy-Pilot Study. 4. November October 29-November 1, 2020, SSB-15, Virtual Congress, National Congress of immunotherapy and Oncology.

Ask Liv Expert